Impact of disease exposure time and treatment in patients with migraine

• Autor(a) principal: Vilela, Thaís Brito
• Data de Publicação: 2023
• Outros Autores: Cunha, Pedro Henrique Ribeiro da, Nicolato, Rodrigo, Lima , Isabela Maria Magalhães
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Debates em Psiquiatria (Online)
• Texto Completo: https://revistardp.org.br/revista/article/view/472
• topic: enxaqueca sem aura; angústia psicológica; idade de início; tempo para o tratamento; transtornos de enxaqueca; cefaleia; migraine without aura; psychological distress; age of onset; time-to-treatment; migraine disorders; headache; migraña sin aura; distrés psicológico; edad de inicio; tiempo de tratamiento; trastornos migrañosos; cefaleas

Introduction: migraine is responsible for the impact on functionality and psychological suffering of individuals who experience this condition. The severity of migraine symptoms and exposure time are associated with and relate to the age of onset of migraine and early treatment. Objective: The objective of this article is to verify whether there is an association between the time of exposure to migraine and the prevalence of depressive and anxious symptoms, as well as to identify the direct or indirect relationship between the duration of treatment on symptoms of psychiatric disorders and the decrease in the impact of migraine. disease in patients' lives. Method: this research constitutes a cross-sectional descriptive study, carried out at a unit specialized in migraine patient care with a sample divided into control group, episodic migraine, and chronic migraine. Results and conclusions: it was concluded that age-matched patients with either chronic migraine (CM) or episodic migraine (EM) reported similar headache onset periods, but have different treatment time (CM = 15 months and EM = 34 months). In addition, the chronic migraine group had higher disease burden.